Morning versus evening exercise: Its effect on body composition and weight loss

Not Applicable

Active, not recruiting

• Conditions: Overweight; Obesity; Diet and Nutrition - Obesity; Public Health - Health promotion/education

• Registration Number: ACTRN12616000457448
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-04-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 95

Inclusion Criteria

Participants will be recruited based on the following inclusion criteria:
i.be aged between 18 and 60 years
ii.have a body mass index greater than or equal to 25 kg/m2
iii.be insufficiently active, defined as participating in less than 150 minutes of MVPA per week (by self-report)
iv.have been weight stable in the previous 3 months (+/-3 kg by self-report)
v.otherwise healthy and cleared for exercise based on the Exercise and Sports Science Australia Adult Pre-Exercise Screening System

Exclusion Criteria

Participants will be excluded based on any of the following criteria:
i.participate in shift work
ii.are pregnant or expecting to be pregnant during the study period
iii.taking any medication that would affect food intake, appetite or physical activity levels, weight loss, or metabolism
iv.have a body weight greater than 150 kg, due to limitations of the DXA machine

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body composition (DXA)[A DXA scan will be performed at baseline, mid-intervention (week 6), post-intervention (week 13) and at follow-up (3- and 6-months post intervention completion)<br>];waist circumference[Waist circumference will be measured at baseline, mid-intervention (week 6), post-intervention (week 13) and at follow-up (3- and 6-months post intervention completion)];body mass index (height and weight)[Body mass index will be measured at baseline, mid-intervention (week 6), post-intervention (week 13) and at follow-up (3- and 6-months post intervention completion)]